Literature DB >> 14592981

TFIIIB is phosphorylated, disrupted and selectively released from tRNA promoters during mitosis in vivo.

Jennifer A Fairley1, Pamela H Scott, Robert J White.   

Abstract

Mitosis involves a generalized repression of gene expression. In the case of RNA polymerase III transcription, this is due to phosphorylation-mediated inactivation of TFIIIB, an essential complex comprising the TATA-binding protein TBP and the TAF subunits Brf1 and Bdp1. In HeLa cells, this repression is mediated by a mitotic kinase other than cdc2-cyclin B and is antagonized by protein phosphatase 2A. Brf1 is hyperphosphorylated in metaphase-arrested cells, but remains associated with promoters in condensed chromosomes, along with TBP. In contrast, Bdp1 is selectively released. Repression can be reversed by raising the concentration of Brf1 or Bdp1. The data support a model in which hyperphosphorylation disrupts TFIIIB during mitosis, compromising its ability to support transcription.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14592981      PMCID: PMC275401          DOI: 10.1093/emboj/cdg544

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  42 in total

Review 1.  The RNA polymerase III transcription apparatus.

Authors:  E P Geiduschek; G A Kassavetis
Journal:  J Mol Biol       Date:  2001-06-29       Impact factor: 5.469

2.  Association of human TFIID-promoter complexes with silenced mitotic chromatin in vivo.

Authors:  Rossitza Christova; Thomas Oelgeschläger
Journal:  Nat Cell Biol       Date:  2002-01       Impact factor: 28.824

3.  The RNA polymerase III transcription initiation factor TFIIIB participates in two steps of promoter opening.

Authors:  G A Kassavetis; G A Letts; E P Geiduschek
Journal:  EMBO J       Date:  2001-06-01       Impact factor: 11.598

Review 4.  Recruitment of RNA polymerase III to its target promoters.

Authors:  Laura Schramm; Nouria Hernandez
Journal:  Genes Dev       Date:  2002-10-15       Impact factor: 11.361

5.  A common mechanism for mitotic inactivation of C2H2 zinc finger DNA-binding domains.

Authors:  Sinisa Dovat; Tapani Ronni; Dana Russell; Roger Ferrini; Bradley S Cobb; Stephen T Smale
Journal:  Genes Dev       Date:  2002-12-01       Impact factor: 11.361

6.  Retinoblastoma protein disrupts interactions required for RNA polymerase III transcription.

Authors:  J E Sutcliffe; T R Brown; S J Allison; P H Scott; R J White
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

7.  Direct activation of RNA polymerase III transcription by c-Myc.

Authors:  Natividad Gomez-Roman; Carla Grandori; Robert N Eisenman; Robert J White
Journal:  Nature       Date:  2003-01-16       Impact factor: 49.962

8.  TBP dynamics in living human cells: constitutive association of TBP with mitotic chromosomes.

Authors:  Danyang Chen; Craig S Hinkley; R William Henry; Sui Huang
Journal:  Mol Biol Cell       Date:  2002-01       Impact factor: 4.138

9.  CK2 forms a stable complex with TFIIIB and activates RNA polymerase III transcription in human cells.

Authors:  Imogen M Johnston; Simon J Allison; Jennifer P Morton; Laura Schramm; Pamela H Scott; Robert J White
Journal:  Mol Cell Biol       Date:  2002-06       Impact factor: 4.272

10.  Different human TFIIIB activities direct RNA polymerase III transcription from TATA-containing and TATA-less promoters.

Authors:  L Schramm; P S Pendergrast; Y Sun; N Hernandez
Journal:  Genes Dev       Date:  2000-10-15       Impact factor: 11.361

View more
  40 in total

1.  The Saccharomyces cerevisiae TRT2 tRNAThr gene upstream of STE6 is a barrier to repression in MATalpha cells and exerts a potential tRNA position effect in MATa cells.

Authors:  Tiffany A Simms; Elsy C Miller; Nicolas P Buisson; Nithya Jambunathan; David Donze
Journal:  Nucleic Acids Res       Date:  2004-09-30       Impact factor: 16.971

2.  Human La is found at RNA polymerase III-transcribed genes in vivo.

Authors:  Jennifer A Fairley; Theodoros Kantidakis; Niall S Kenneth; Robert V Intine; Richard J Maraia; Robert J White
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-12       Impact factor: 11.205

3.  tRNA genes protect a reporter gene from epigenetic silencing in mouse cells.

Authors:  Thomas Ebersole; Jung-Hyun Kim; Alexander Samoshkin; Natalay Kouprina; Adam Pavlicek; Robert J White; Vladimir Larionov
Journal:  Cell Cycle       Date:  2011-08-15       Impact factor: 4.534

4.  Regulation of TFIIIB during F9 cell differentiation.

Authors:  Dimitris Athineos; Lynne Marshall; Robert J White
Journal:  BMC Mol Biol       Date:  2010-03-12       Impact factor: 2.946

Review 5.  Cell growth- and differentiation-dependent regulation of RNA polymerase III transcription.

Authors:  Hélène Dumay-Odelot; Stéphanie Durrieu-Gaillard; Daniel Da Silva; Robert G Roeder; Martin Teichmann
Journal:  Cell Cycle       Date:  2010-09-01       Impact factor: 4.534

6.  Enhanced RNA polymerase III-dependent transcription is required for oncogenic transformation.

Authors:  Sandra A S Johnson; Louis Dubeau; Deborah L Johnson
Journal:  J Biol Chem       Date:  2008-05-01       Impact factor: 5.157

Review 7.  RNA polymerase III repression by the retinoblastoma tumor suppressor protein.

Authors:  Alison Gjidoda; R William Henry
Journal:  Biochim Biophys Acta       Date:  2012-10-12

8.  Quantitative mass spectrometry of TATA binding protein-containing complexes and subunit phosphorylations during the cell cycle.

Authors:  Wwm Pim Pijnappel; Annemieke Kolkman; Marijke Pa Baltissen; Albert Jr Heck; Ht Marc Timmers
Journal:  Proteome Sci       Date:  2009-12-24       Impact factor: 2.480

9.  Dr1 (NC2) is present at tRNA genes and represses their transcription in human cells.

Authors:  Theodoros Kantidakis; Robert J White
Journal:  Nucleic Acids Res       Date:  2009-12-03       Impact factor: 16.971

10.  Centromeric localization of dispersed Pol III genes in fission yeast.

Authors:  Osamu Iwasaki; Atsunari Tanaka; Hideki Tanizawa; Shiv I S Grewal; Ken-Ichi Noma
Journal:  Mol Biol Cell       Date:  2009-11-12       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.